Dine Brands Global, Inc. (DIN)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	324	459	767	1,013	1,305	952
Market Cap Growth	-31.82%	-40.15%	-24.30%	-22.40%	37.06%	-32.10%
Enterprise Value	1,770	1,875	2,255	2,452	2,779	2,698
Last Close Price	21.08	28.92	45.00	56.48	64.44	49.03
PE Ratio	7.06	7.29	8.08	12.83	13.66	-
Forward PE	4.85	5.14	8.11	9.67	11.26	12.30
PS Ratio	0.37	0.56	0.92	1.11	1.46	1.38
PB Ratio	-	-2.12	-3.05	-3.36	-5.38	-2.68
P/FCF Ratio	3.50	4.88	8.16	18.75	7.29	11.13
P/OCF Ratio	2.97	4.24	5.85	11.34	6.67	9.87
PEG Ratio	-	1.54	1.54	1.54	1.54	1.54
EV/Sales Ratio	2.09	2.31	2.71	2.70	3.10	3.91
EV/EBITDA Ratio	9.28	9.09	10.05	11.46	11.95	19.86
EV/EBIT Ratio	11.78	11.22	11.95	13.93	14.42	29.00
EV/FCF Ratio	19.13	19.93	24.00	45.39	15.53	31.53
Debt / Equity Ratio	-7.72	-7.53	-6.32	-5.79	-7.31	-5.73
Debt / EBITDA Ratio	8.59	7.88	7.07	8.10	7.59	13.58
Debt / FCF Ratio	17.73	17.28	16.88	32.26	9.92	23.76
Asset Turnover	0.49	0.46	0.46	0.47	0.44	0.33
Quick Ratio	0.66	0.68	0.60	0.83	1.17	1.45
Current Ratio	0.86	0.87	0.78	1.02	1.40	1.68
Return on Assets (ROA)	5.39%	5.92%	6.51%	5.67%	5.91%	2.82%
Return on Capital (ROIC)	6.75%	7.61%	8.50%	7.40%	7.50%	3.54%
Return on Capital Employed (ROCE)	11.10%	12.40%	14.70%	12.50%	12.10%	5.40%
Earnings Yield	13.76%	14.14%	12.67%	8.01%	7.50%	-10.92%
FCF Yield	28.54%	20.50%	12.26%	5.33%	13.71%	8.99%
Dividend Yield	9.68%	7.05%	4.53%	3.52%	0.62%	1.55%
Payout Ratio	68.28%	48.24%	32.64%	37.93%	-	-
Buyback Yield / Dilution	1.05%	2.04%	4.14%	5.86%	-4.07%	5.89%
Total Shareholder Return	10.73%	9.09%	8.68%	9.38%	-3.45%	7.44%

Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q